CORRECTION: Bio-Path Holdings Q2 EPS $(0.53) Misses $(0.44) Estimate
Portfolio Pulse from Benzinga Newsdesk
Bio-Path Holdings reported Q2 losses of $(0.53) per share, missing the analyst consensus estimate of $(0.44) by 20.45 percent. This represents a 26.19 percent decrease over losses from the same period last year.
August 15, 2023 | 11:15 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bio-Path Holdings' Q2 earnings missed estimates, with losses increasing by 26.19% YoY.
Bio-Path Holdings reported a larger than expected loss for Q2, missing analyst estimates. This negative earnings surprise is likely to negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100